RCM
ELV icon

Royal Capital Management’s Elevance Health ELV Stock Holding History

Royal Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-130,000
Closed -$10.6M – 23
2013
Q2 		$10.6M Buy
+130,000
New +$9.73M 3.69% 16

Other funds holding ELV

Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Royal Capital Management's ELV Position: Q3 2013 in Review

Royal Capital Management sold out of Elevance Health (ELV) in Q3 2013, closing a stake of 130,000 shares — an estimated $10.6M sold.

Royal Capital Management first reported a position in ELV in Q2 2013 and held it in 1 quarter. The position peaked at $10.6M in Q2 2013. 613 funds tracked by Wall St. Rank hold ELV as of Q3 2013.

  • Royal Capital Management reported no remaining Elevance Health position as of Q3 2013 after selling out during the quarter.
  • Royal Capital Management sold 130,000 Elevance Health shares in Q3 2013, an estimated $10.6M.
  • Royal Capital Management first reported a position in Elevance Health in Q2 2013 and held it in 1 quarter.
  • Royal Capital Management's Elevance Health position peaked at $10.6M in Q2 2013.
  • 613 funds tracked by Wall St. Rank held Elevance Health as of Q3 2013.

Based on Royal Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.